Innovent

News

Innovent gets OK for China's first home-grown IL-23p19 drug

Innovent has picked up approval in China for Pecondle, its anti-IL-23p19 antibody, as a treatment for moderate-to-severe plaque psoriasis.

News

Innovent files high-dose mazdutide for obesity in China

Innovent has filed a new high-strength version of its weight-loss drug mazdutide in China, aiming to help people with severe obesity.

News

Three Chinese label boxes of Innovent's mazdutide

Pressure rises on Novo as Innovent drug tops Ozempic

Innovent's dual glucagon and GLP-1 agonist mazdutide outperforms Novo Nordisk's Ozempic in overweight people with diabetes.

News

Takeda builds in cancer with monster $11.4bn Innovent deal

Takeda has partnered with China's Innovent for a pair of late-stage cancer therapies, in a deal that includes an upfront payment of $1.2bn.

News

Roche licenses Innovent ADC that could challenge Amgen drug

Roche licenses rights to a DLL3-targeted ADC from China's Innovent, hoping to bring a competitor to Amgen's lung cancer therapy Imdelltra to market.

News

Innovent throws its hat further into China's GLP-1 ring

Innovent Biologics is planning a second filing for its dual GLP-1/glucagon agonist mazdutide in China, as it tries to carve out a share of a market currently dominated by Novo Nordisk and E

Innovent gets OK for China's first home-grown IL-23p19 drug

Innovent files high-dose mazdutide for obesity in China

Pressure rises on Novo as Innovent drug tops Ozempic

Takeda builds in cancer with monster $11.4bn Innovent deal

Roche licenses Innovent ADC that could challenge Amgen drug

Innovent throws its hat further into China's GLP-1 ring

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

Innovent

Editor's Picks